6

6 Manner of ascertaining price for pharmaceutical benefits

(1) For the purposes of subsection 84C(7) of the Act, the price for a pharmaceutical benefit (of a particular quantity or number of units) is to be ascertained by adding: (a) the Commonwealth price for the supply of the benefit by an approved pharmacist, worked out in accordance with the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020); and (b) the amount of the additional patient charge; and (c) either: (i) if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.48; or (ii) if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.91.

Note: This subsection complies with subsection 84C(8) of the Act because, to comply with subsection 98B(2) of the Act, the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020):

(a) uses as a basis the approved ex‑manufacturer price, a proportional ex‑manufacturer price or the basic wholesale price; and
(b) provides for the addition of other fees and amounts determined by the Tribunal that made the determination.

(2) However, the price for the pharmaceutical benefit must not be more than the amount that an approved pharmacist may charge for the supply of the benefit under subsection 87(2) or (3) of the Act.